MENU
ARGNF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Argen X (ARGNF) Ownership - Who owns Argen X?
Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more
Profile
Industry
N/A
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
1148
Web
https://www.argenx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
45.05B
P/E Ratio
34.77
Total Cash
3.93B
Projected Growth
1.18
Total Debt
43.15M
Revenue
3.05B
Risk (Beta)
-0.44
Dividend Yield
N/A
Total Cash/Share
64.19
Total Debt/Equity
N/A
Revenue/Share
44.70 USD as % of share price
Fundamentals
ARGNF
Capitalization
45.1B
P/E Ratio
34.77
Risk (Beta)
-0.44
Dividend Yield
N/A
Total Cash
3.93B
Total Cash/Share
64.19
Total Debt
43.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
1.18
Revenue/Share (as % of the share price)
44.70%
Revenue
3.05B
ROE
N/A
Book Value
6.1B
P/B Ratio
6.86
Cash Flow
N/A
Earnings
21.27
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7.26M
Current Ratio
5.60
Current Revenue Per Employee
578377.70
Dividends Per Share - Security
N/A
EBITDA
690M
Float
N/A
Float - Current
N/A
Gross Income Margin
88.32
Revenue To Assets
21.39
Shares Held By Institutions
25.7B
Shares Outstanding - Current
61.2M
Total Liabilities
1.08B
Total Volume MTD
N/A
Value
-1
Gain YTD
4.720
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
1148
Web
https://www.argenx.com